
Ashwin N Ananthakrishnan MD MPH
Inflammatory Bowel Disease
Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School.
Join to View Full Profile
165 Cambridge StreetBoston, MA 02114
Phone+1 617-726-0267
Dr. Ananthakrishnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2007 - 2010
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2004 - 2007
Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 2003
Certifications & Licensure
MA State Medical License 2010 - 2027
ME State Medical License 2021 - 2026
NH State Medical License 2021 - 2025
RI State Medical License 2021 - 2024
WI State Medical License 2005 - 2011
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2013-2014, 2016-2017
Clinical Trials
- Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease Start of enrollment: 2017 Nov 13
- Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) Start of enrollment: 2018 Nov 10
Publications & Presentations
PubMed
- Collagen-binding probe PET/MR for distinguishing fibrotic from inflammatory strictures in Crohn's disease.Antonino Andrea Blandino, Peter Caravan, Rocco Ricciardi, Liliana G Bordeianou, Hiroko Kunitake
European Journal of Nuclear Medicine and Molecular Imaging. 2026-05-01 - Patient-Inclusive Recruitment in Inflammatory Bowel Disease Trials: Key Takeaways From the 2025 Strategic Alliance for Intercultural Advocacy in GI-American Gastroente...Tina Aswani-Omprakash, Jalpa Devi, Madhura Balasubramaniam, Ashwin N Ananthakrishnan, Neilanjan Nandi
Gastroenterology. 2026-05-01 - Patient-Inclusive Recruitment in Inflammatory Bowel Disease Trials: Key Takeaways From the 2025 Strategic Alliance for Intercultural Advocacy in GI-American Gastroente...Tina Aswani-Omprakash, Jalpa Devi, Madhura Balasubramaniam, Ashwin N Ananthakrishnan, Neilanjan Nandi
Clinical Gastroenterology and Hepatology. 2026-05-01
Journal Articles
- CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis PatientsMichael S Gee, Ashwin N Ananthakrishnan, Digestive Diseases and Sciences
- Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women Without Celiac Disease: A Prospective Cohort StudyBenjamin Lebwohl, Paul Lochhead, Ashwin N Ananthakrishnan, Andrew T Chan, Kristin E Burke, James M Richter, Hamed Khalili, Nature
- Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative ColitisJay Luther, Francis Colizzo, Ashwin N Ananthakrishnan, Amar Vedamurthy, John J Garber, Hamed Khalili, Digestive Diseases and Sciences
Press Mentions
Precision-Medicine Approach Improves IBD Infliximab OutcomesMay 12th, 2025
Does Bezlotoxumab Boost FMT Efficacy in IBD Patients with Recurrent CDI?November 11th, 2024
ACG/ASGE Task Force Identifies 19 Indicators for Achieving Quality GI EndoscopySeptember 11th, 2024
Grant Support
- Determinants of inception of inflammation in inflammatory bowel diseasesMASSACHUSETTS GENERAL HOSPITAL2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









